SK282952B6 - Farmaceutický prostriedok s obsahom 5,6-diizobutyroyloxy-2- metylaminotetralínu a jeho použitie - Google Patents

Farmaceutický prostriedok s obsahom 5,6-diizobutyroyloxy-2- metylaminotetralínu a jeho použitie Download PDF

Info

Publication number
SK282952B6
SK282952B6 SK1254-97A SK125497A SK282952B6 SK 282952 B6 SK282952 B6 SK 282952B6 SK 125497 A SK125497 A SK 125497A SK 282952 B6 SK282952 B6 SK 282952B6
Authority
SK
Slovakia
Prior art keywords
chf
receptors
administration
therapy
heart failure
Prior art date
Application number
SK1254-97A
Other languages
English (en)
Slovak (sk)
Other versions
SK125497A3 (en
Inventor
Paolo Chiesi
Stefano Bongrani
Roberta Razzetti
Maurizio Civelli
Alberto Umile
Original Assignee
Chiesi Farmaceutici S. P. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici S. P. A. filed Critical Chiesi Farmaceutici S. P. A.
Publication of SK125497A3 publication Critical patent/SK125497A3/sk
Publication of SK282952B6 publication Critical patent/SK282952B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK1254-97A 1995-03-17 1996-03-13 Farmaceutický prostriedok s obsahom 5,6-diizobutyroyloxy-2- metylaminotetralínu a jeho použitie SK282952B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95MI000532A IT1275935B1 (it) 1995-03-17 1995-03-17 Derivato di aminotetralina per la terapia di malattie cardiovascolari
PCT/EP1996/001060 WO1996029065A2 (en) 1995-03-17 1996-03-13 Aminotetralin derivative for the therapy of cardiovascular diseases

Publications (2)

Publication Number Publication Date
SK125497A3 SK125497A3 (en) 1998-02-04
SK282952B6 true SK282952B6 (sk) 2003-01-09

Family

ID=11370947

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1254-97A SK282952B6 (sk) 1995-03-17 1996-03-13 Farmaceutický prostriedok s obsahom 5,6-diizobutyroyloxy-2- metylaminotetralínu a jeho použitie

Country Status (31)

Country Link
US (2) US6013678A (de)
EP (2) EP0814791B1 (de)
JP (1) JPH11502211A (de)
KR (1) KR100391143B1 (de)
CN (1) CN1112920C (de)
AT (1) ATE218856T1 (de)
AU (1) AU702656B2 (de)
BR (1) BR9607996A (de)
CA (1) CA2215671A1 (de)
CZ (1) CZ288488B6 (de)
DE (1) DE69621786T2 (de)
DK (1) DK0814791T3 (de)
EA (1) EA000937B1 (de)
EE (1) EE04040B1 (de)
ES (1) ES2177769T3 (de)
HK (2) HK1004802A1 (de)
HU (1) HUP9801686A3 (de)
IL (1) IL117518A (de)
IT (1) IT1275935B1 (de)
LT (1) LT4355B (de)
LV (1) LV11882B (de)
MX (1) MX9706971A (de)
NO (1) NO317402B1 (de)
NZ (1) NZ303993A (de)
PL (1) PL183347B1 (de)
PT (1) PT814791E (de)
SI (1) SI9620036B (de)
SK (1) SK282952B6 (de)
TR (1) TR199700963T1 (de)
WO (1) WO1996029065A2 (de)
ZA (1) ZA962073B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2695157B2 (ja) * 1986-12-29 1997-12-24 松下電器産業株式会社 可変パイプラインプロセッサ
WO2000076544A1 (en) * 1996-03-13 2000-12-21 Chiesi Farmaceutici S.P.A. Aminotetralin derivative for the therapy of cardiovascular diseases
EE200100663A (et) * 1999-06-09 2003-04-15 Chiesi Farmaceutici S.P.A. Aminotetraliini derivaat kardiovaskulaarsete haiguste raviks
EP1331004A3 (de) * 1999-06-09 2003-08-06 CHIESI FARMACEUTICI S.p.A. Aminotetralin Derivat zur Behandlung von kardiovaskulären Erkrankungen
IT1313583B1 (it) * 1999-07-30 2002-09-09 Chiesi Farma Spa Derivati 2-amminotetralinici per la terapia del glaucoma.
IL152751A0 (en) * 2000-05-12 2003-06-24 Chiesi Farma Spa Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
SE0101854L (sv) * 2001-05-28 2002-11-29 Bioneris Ab Användning av en förening med en negativt laddad region av grupper för behandling av restenos.
EP1384708A1 (de) * 2002-07-26 2004-01-28 CHIESI FARMACEUTICI S.p.A. Verfahren zur Herstellung der Form I von Nolomirol Hydrochlorid
US20050101668A1 (en) * 2003-07-24 2005-05-12 Chiesi Farmaceutici S.P.A. Aminotetralin derivatives as a medicament for the treatment and prevention of myocardial ischemic conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4134997A (en) * 1977-03-01 1979-01-16 University Of Iowa Research Foundation Effect of an aminotetralin derivative on coronary blood flow in infarcted hearts
SU998342A1 (ru) 1981-12-11 1983-02-23 Предприятие П/Я А-3732 Способ получени синтетического цеолита типа @
IT1218322B (it) * 1982-06-10 1990-04-12 Chiesi Farma Spa Derivati di 1,2,3,4-tetraidronaftalene,procedimento di preparazione e relative composizioni farmaceutiche

Also Published As

Publication number Publication date
PL183347B1 (pl) 2002-06-28
LV11882B (en) 1998-03-20
LV11882A (lv) 1997-12-20
HUP9801686A3 (en) 1999-10-28
EP0814791A1 (de) 1998-01-07
EA000937B1 (ru) 2000-06-26
NO317402B1 (no) 2004-10-25
CN1112920C (zh) 2003-07-02
CN1181699A (zh) 1998-05-13
NO974267L (no) 1997-11-07
SK125497A3 (en) 1998-02-04
LT4355B (lt) 1998-06-25
IL117518A (en) 2001-05-20
EP1216702A3 (de) 2002-09-04
WO1996029065A2 (en) 1996-09-26
CA2215671A1 (en) 1996-09-26
PL322284A1 (en) 1998-01-19
WO1996029065A3 (en) 1996-11-28
EA199700243A1 (ru) 1998-02-26
SI9620036A (sl) 1998-02-28
NO974267D0 (no) 1997-09-16
HK1048060A1 (zh) 2003-03-21
IT1275935B1 (it) 1997-10-24
PT814791E (pt) 2002-10-31
ZA962073B (en) 1996-11-27
NZ303993A (en) 2000-12-22
TR199700963T1 (xx) 1998-02-21
DE69621786D1 (de) 2002-07-18
EE04040B1 (et) 2003-06-16
AU5107296A (en) 1996-10-08
HK1004802A1 (en) 1998-12-11
EP1216702A2 (de) 2002-06-26
EP0814791B1 (de) 2002-06-12
ATE218856T1 (de) 2002-06-15
ITMI950532A1 (it) 1996-09-17
CZ286697A3 (cs) 1998-03-18
AU702656B2 (en) 1999-02-25
HUP9801686A2 (hu) 1999-06-28
ITMI950532A0 (it) 1995-03-17
SI9620036B (sl) 2002-10-31
EE9700231A (et) 1998-04-15
CZ288488B6 (en) 2001-06-13
ES2177769T3 (es) 2002-12-16
BR9607996A (pt) 1998-06-23
IL117518A0 (en) 1996-07-23
DE69621786T2 (de) 2003-01-02
US6103760A (en) 2000-08-15
KR19980703030A (ko) 1998-09-05
KR100391143B1 (ko) 2003-11-28
LT97147A (en) 1998-02-25
MX9706971A (es) 1997-11-29
US6013678A (en) 2000-01-11
DK0814791T3 (da) 2002-10-07
JPH11502211A (ja) 1999-02-23

Similar Documents

Publication Publication Date Title
KAYDEN et al. Procaine amide: a review
SK282952B6 (sk) Farmaceutický prostriedok s obsahom 5,6-diizobutyroyloxy-2- metylaminotetralínu a jeho použitie
AU766230B2 (en) Aminotetralin derivative for the therapy of cardiovascular diseases
Brogden et al. Gallopamil: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in ischaemic heart disease
AU643487B2 (en) Use of optically pure s(-) atenolol for the treatment of cardiovascular disorders
WO2000076544A1 (en) Aminotetralin derivative for the therapy of cardiovascular diseases
EP1331004A2 (de) Aminotetralin Derivat zur Behandlung von kardiovaskulären Erkrankungen
Plummer Pharmacology of new hypotensive drugs
Kaplan Alpha and beta receptor blocking drugs in the treatment of hypertension
Siegemund Oral anti-hypertensive drugs and anaesthesia
Zelis et al. The Use of Calcium Entry Blockers in Congestive Heart Failure